Nanotechnological Applications in Virology explores the use of nanoparticles-based technologies to fight against viruses, also discussing the use of nanoparticles in the preparation of nano masks and as sanitizing agents. The role of nanotechnology against HIV, Hepatitis, Influenza, Herpes, Ebola and Zika using rapid detection and diagnostic techniques is included, as is a brief description of SARS, MERS, the novel Coronavirus, and recent advancements in its treatment process. Other sections cover the formulation of novel nano-vaccines for the treatment and control of viral infections like HIV, Hepatitis and COVID-19. Included toxicological studies of nanoparticles provide readers with a brief overview on global scenarios regarding viral infections.
Nanotechnology is the present age technology, with wide usage in different areas of medical science, including drug delivery, gene therapy, antimicrobials, biosensors and bio-labelling. Nanoparticles play a competent role as an anti-infection agent and thus act as efficient antiviral agents.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
1. Nanotechnology and its potential role against viruses
2. Nanotechnology based innovations to fight against viral infections
3. Functionalized metal and metal oxide nanoparticles/nanocomposites against viruses
4. Unique advantages of nanomaterials in drug delivery and therapy against viruses
5. Engineered nanoparticles for therapeutic applications
6. Intranasal delivery of nanoparticles in HIV:�A revolution in therapeutics
7. Application of Nanomaterials as Nanomasks
8. Nanomaterials as Sanitizing Agents
Section II Nanotechnology for Detection and Inhibition of Viral Infections
9. Harnessing nanotechnology for visualizing viruses and host-pathogen interactions
10. Nanotechnological tools for the inhibition of Ebola, Zika and Herpes Simplex virus
11. Nanotechnology: New frontiers in anti HIV therapy
12. Nanoparticles based immunoassays for early and rapid detection of HIV and other viral?infections
13. Nanobiotechnology: The union of Sciences in the fight against viruses
Section III Nanotechnology against Novel Coronavirus
14. SARS, MERS and COVID-19: Emerging threats to public health
15. Origin, evolution and pathogenesis of Corona virus
16. Recent advancements in diagnosis, treatment and vaccination for COVID-19
Section IV Nanotechnology-based Vaccines
17. Nanoformulated vaccines against viral infections: a review
18. Development of novel vaccines using nanomaterials against COVID-19
Section V Toxicological challenges
19. Toxicological considerations of use of nanoparticles in the treatment of viral infections
Authors
Mahendra Rai Senior Visiting Professor, Federal University of Piaui, Brazil.Prof. Mahendra Rai is a UGC Basic Science Research Faculty Fellow and former Head of the Department of Biotechnology at Sant Gadge Baba Amravati University, India. He is currently a senior visiting professor in the Department of Chemistry at the Federal University of Piaui (UFPI), Brazil.
His areas of expertise include microbial biotechnology and nanobiotechnology, focusing on the green synthesis of metal nanoparticles using fungi and their applications as nanoantimicrobials against pathogenic microbes. His research is interdisciplinary, integrating microbial biotechnology with nanotechnology.
Professor Rai has received several prestigious awards, including the Father T.A. Mathias Award from the All India Association for Christian Higher Education and the Medini Award from the Government of India. He has participated in multiple international collaborations and has held visiting positions at various institutions, including the University of Geneva (Switzerland), Debrecen University (Hungary), and Nicolaus Copernicus University (Poland).
Alka Yadav Department of Biotechnology, SGB Amravati University, India. Dr Yadav PhD has 10 years of experience in publishing research and review articles in high impact factor journals. She has worked as guest reviewer in prestigious science publications such as Springer, Wiley, Taylor and Frances and has been recognized by Elsevier for her article Silver nanoparticles: as a new generation of antimicrobials which has been cited over 5000 times. She has several book chapters along with a process patent to her credit
